Ikris Pharma International (IPI) has established a strong network of 200+ globally validated suppliers in the EU, USA, Australia, Japan, Canada, Korea, Malaysia and Latin America and various other markets for direct sourcing and procurement of pharmaceutical products, as well as support for R&D projects.
The dedication to serving our customers is the top priority for IPI's operational activities. Delays in treatments have a direct impact on patients' lives, and delays in R&D studies impacts advancements in future product development, which also affects patients' lives. We at IPI take pride in our work and adhere to strict deadlines by strengthening our supply chain networks to meet the demands of our valued customers.
Ikris Pharma International (IPI), has its own EU-GDP certified warehouse in Belgium, operates in accordance with EU SOPs and GDP guidelines, ensuring precise execution in all aspects of pharmaceutical operations. You can rely on us for consistent excellence and trust in industry standards.
Ikris Pharma International (IPI) specialized in handling start to end cold chain shipments, safeguarding the medicines integrity and authenticity through its strong global networks by adhering to EU-SOPs in accordance with strict European regulations. IPI completely rely on its unmatched proficiency in transporting delicate cargo. We maintain customer’s transparency by keeping them informed of the entire medication traceability process.
RLDs and Clinical Trial Sourcing: Specialized in RLDs clinical trial sourcing, IPI facilitates the procurement of pharmaceuticals for BA/BE studies and R&D activities efficiently, contributing to advancements in medical science with precision and reliability.
Named Patient Program (NPP): IPI's Named Patient Program ensures rapid and easy access to unregistered medicines to their home country for individual patients, addressing unique healthcare needs with compassion and efficiency.
Pharmaceutical Exporter: IPI is a reputable pharmaceutical exporter that follows global quality standards. Our dedication to regulatory compliance and transparent business practices establishes us as a dependable international healthcare partner.
Choose IPI for cross-functional expertise that delivers impactful solutions in RLD and CT sourcing, Named Patient Programs, and Pharmaceutical Exports.
The term “Managed Access Program” refers to the authorized programs which allow patients access to hard-to-access medicines which are not available in their native country.
Learn MoreA Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent.
Learn MoreWe are a globally recognized pharmaceutical wholesaler and service provider specializing in quality medicines. Our world-class facilities....
Learn MoreIkris Pharma International is a global service provider offering accessibility to a wide range of pharmaceutical products to the patients, distributors and healthcare sector. We are amongst the leading pharmaceutical wholesalers in Belgium having a wide network to supply specialty medicines across the globe under compliant regulations. As a distributor of pharmaceuticals our highest priority is to maintain high quality standards throughout the supply chain. Our processes and procedures are executed under the EU guidelines on Good Distribution Practices of medicinal products for the human use. Besides that, providing consistent customer services and maintaining client anonymity are amongst our other top priorities. By securing medicines through authentic sources, we contribute to the safety and reliability for the patients needing such medicines.